Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.
about
Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndromePractical guidelines for managing adults with 22q11.2 deletion syndromePersistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice.Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disordersFeasibility and preliminary efficacy data from a computerized cognitive intervention in children with chromosome 22q11.2 deletion syndrome.Prodromal symptoms in adolescents with 22q11.2 deletion syndrome and schizotypal personality disorder.Contribution of congenital heart disease to neuropsychiatric outcome in school-age children with 22q11.2 deletion syndrome.Subthreshold psychotic symptoms in 22q11.2 deletion syndrome.How might stress contribute to increased risk for schizophrenia in children with chromosome 22q11.2 deletion syndrome?Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.Disrupted fornix integrity in children with chromosome 22q11.2 deletion syndromeAnxiety Disorders and Perceptual Disturbances in Adolescents with 22q11.2 Deletion Syndrome Treated with SSRI: A Case Series.Response to clozapine in a clinically identifiable subtype of schizophrenia.Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated.Computerized neurocognitive profile in young people with 22q11.2 deletion syndrome compared to youths with schizophrenia and at-risk for psychosis.No age effect in the prevalence and clinical significance of ultra-high risk symptoms and criteria for psychosis in 22q11 deletion syndrome: Confirmation of the genetically driven risk for psychosis?Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular eraAn examination of the relationship of anxiety and intelligence to adaptive functioning in children with chromosome 22q11.2 deletion syndromeThe hippocampi of children with chromosome 22q11.2 deletion syndrome have localized anterior alterations that predict severity of anxiety.22q11.2 deletion syndromeUltra high risk status and transition to psychosis in 22q11.2 deletion syndromeWhite matter microstructural abnormalities in girls with chromosome 22q11.2 deletion syndrome, Fragile X or Turner syndrome as evidenced by diffusion tensor imaging.Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study.Facial emotion perception by intensity in children and adolescents with 22q11.2 deletion syndrome.Performance on a computerized neurocognitive battery in 22q11.2 deletion syndrome: A comparison between US and Israeli cohorts.Multimodal investigation of triple network connectivity in patients with 22q11DS and association with executive functions.Neuropsychiatric aspects of 22q11.2 deletion syndrome: considerations in the prenatal setting.Negative and paranoid symptoms are associated with negative performance beliefs and social cognition in 22q11.2 deletion syndrome.Implication of reward alterations in the expression of negative symptoms in 22q11.2 deletion syndrome: a behavioural and DTI study.Schizotypal traits in adolescents with 22q11.2 deletion syndrome: validity, reliability and risk for psychosis.Social cognitive training in adolescents with chromosome 22q11.2 deletion syndrome: feasibility and preliminary effects of the intervention.The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia – relationship with COMT Val108/158 Met polymorphism, gender and symptomatology
P2860
Q26824150-32D91A09-107D-4165-9D0F-456E06E000E4Q27002798-905B9015-DA9F-45C0-9F18-7BB65B8C307DQ30359319-F5F7259C-E88E-4201-B2DD-26DB507893E0Q30458768-96982294-A863-48DF-9FEF-C15582568162Q30644398-0DB6FBBA-0672-4A57-A0E2-4FB00EA960B3Q33878153-993B9504-26BF-4F00-91CD-B8CF3B8618B8Q34131454-B8FEB87F-0235-42A6-8728-19940CB30F18Q34156406-FD597B30-20F7-4286-A99C-415B414060DCQ34669660-6401D6EC-7675-4B91-B110-75A7348011CAQ34847296-B8EA1136-4110-4406-8B9E-9D830305B3E1Q35499123-3EA106C3-FAF9-4699-B69A-64AE3BCDBAFEQ35568668-F3CE9BF9-6B95-4E0B-A7AB-9DBA6AD01871Q35695451-A7AC52A2-0C25-4F8F-92D2-8DA60BE28890Q35704408-0C1032B3-7AFD-4C50-965A-C40B05DC9133Q35738055-59F348B3-0002-4154-823E-A2B2FD5B0383Q36345854-F63E432B-4E9F-491A-A474-3AE1F4113B0DQ36380279-E9CD0B85-6DDF-4A93-B21D-C105D9DB8C48Q36470735-B7912BF5-E59A-4948-9497-E9AC6F855D2AQ36858439-FA86885F-1EB9-4DBF-B489-D07111D98D07Q36988231-9B278A92-D60E-442E-B41B-8DCA128CDE6FQ37274686-9122C606-A989-43EB-A88F-A6A4CC6688C6Q37626841-57DDCC6A-2DAB-49A3-AFEF-4E4962C7BE6EQ38756852-5EE97753-F250-4F0D-B4E7-6ED63D342FEFQ38987751-7E585A44-ACDF-4354-9AD5-2F1F9ADC23E7Q39750431-6B54A0A5-5F37-4246-8162-2F5107DEADD5Q46059050-F713EF98-B007-49CF-B3CD-4CF82EBF3EEAQ47149091-0B2F89E7-4655-4CB8-A7D9-B7EF20092D40Q47433725-85249820-45CB-4BBE-94E0-7E9C2CD6BDC3Q50460088-E1DC81E8-D8A3-448E-874A-AEB6760BCF35Q50544425-08FEAF78-4F25-46A7-9609-3E40FA5224E6Q50590153-AAD96361-9813-4DE3-985E-08D587710E7AQ55383317-DA1B545E-786B-4417-94B7-A4AA1E7E0D8BQ58183040-F759439A-45B1-426E-B19C-DF4FC8DF9234
P2860
Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Attenuated positive symptoms o ...... ome 22q11.2 deletion syndrome.
@ast
Attenuated positive symptoms o ...... ome 22q11.2 deletion syndrome.
@en
type
label
Attenuated positive symptoms o ...... ome 22q11.2 deletion syndrome.
@ast
Attenuated positive symptoms o ...... ome 22q11.2 deletion syndrome.
@en
prefLabel
Attenuated positive symptoms o ...... ome 22q11.2 deletion syndrome.
@ast
Attenuated positive symptoms o ...... ome 22q11.2 deletion syndrome.
@en
P2093
P2860
P1476
Attenuated positive symptoms o ...... some 22q11.2 deletion syndrome
@en
P2093
Cameron Carter
Robert Hendren
Tony J Simon
P2860
P304
P356
10.1016/J.SCHRES.2009.12.011
P407
P577
2010-01-06T00:00:00Z